Jump to content

Hana starts Phase II lung cancer trial

Recommended Posts

http://sanfrancisco.bizjournals.com/san ... rround=lfn

San Francisco Business Times - 1:55 PM PST Friday

Hana Biosciences Inc. said Friday it started a Phase II trial of its drug Talotrexin in patients with lung cancer.

The South San Francisco company (AMEX: HBX) is testing the drug in patients with relapsed or refractory non-small cell lung cancer.

The primary objective of the trial is to show an improvement in overall survival of patients. Secondary goals include safety, response rate and the length of time patients go without the disease progressing.

Hana will present updated information from the trial at a conference in Atlanta in June.

More than a million people around the world die from lung cancer every year.

Link to comment
Share on other sites

Happy to be of assistance Was interesting reading if you can get through it all. I am about a 1/3rd so far.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.